Cognitive Training for Age-Related Distractibility
Trial Summary
What is the purpose of this trial?
A growing body of research has highlighted the importance of frontal regions, at both the functional and structural levels, in age-related declines in attentional and cognitive processing. However, the underlying neurobiological pathophysiological changes in the brain that contribute to these declines are still largely unclear. The objective of this proposal is to investigate neural mechanisms of age-related attentional distractibility, focusing on the neural circuit initiated from the locus coeruleus (LC). In the current proposal, the investigators will test the hypothesis that the neural disconnectivity of LC with the salience network (SN) drives failures of ignoring distractors in older adults. The investigators will examine how LC-SN connectivity is associated with selective attention performance, and how improved LC-SN connectivity through a cognitive training program may lead to improved attentional performance.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment for age-related distractibility?
Research shows that cognitive training programs, including those delivered via tablets or computers, can improve attention and cognitive performance in older adults. Studies have found that such programs enhance skills like selective focus and coordination, suggesting they may help with age-related distractibility.12345
Is cognitive training for age-related distractibility safe for humans?
How does the treatment for age-related distractibility differ from other treatments?
This treatment is unique because it uses a tablet-based program to provide adaptive cognitive training, focusing on improving attention by helping older adults suppress irrelevant sensory stimuli. Unlike other treatments, it is specifically designed to enhance selective attention and processing speed through modality-specific exercises, making it accessible and tailored to individual needs.137910
Eligibility Criteria
This trial is for healthy adults aged 18-75 who can consent to participate. It's not suitable for those with metal implants, pacemakers, severe claustrophobia, braces, a weight over 250 pounds, pregnancy or severe medical/psychiatric conditions like head trauma.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Cognitive Training
Older adult participants complete an attention practice program, preceded and followed by an fMRI scan session featuring an attention task
Follow-up
Participants are monitored for changes in accuracy on the place-face selective attention task and fMRI LC-SN connectivity
Treatment Details
Interventions
- Tablet based adaptive criterion task practice program (Behavioural Intervention)
- Tablet based adaptive multimodal attention practice program (Behavioural Intervention)